Understanding these interactions in detail may provide valuable insights into potential associations between TGF-β signaling and osteosarcoma outcomes, particularly in patients with concomitant conditions such as pulmonary allergic inflammation. The gene discussed is TGFB1; the disease is osteosarcoma.